AstraZeneca and Vodafone enter partnership to improve cardiovascular health

By Admin
The recent announcement of a global partnership between Vodafone and the UKs AstraZeneca is bent on assisting patients with serious cardiovascular condi...

The recent announcement of a global partnership between Vodafone and the UK’s AstraZeneca is bent on assisting patients with serious cardiovascular conditions. This relationship will work with various healthcare professionals using mobile technology to increase patient communication capabilities: both mHealth and internet-based mHealth services.

Taking lead on the project, AstraZeneca’s Intelligent Pharmaceutical Group will spearhead the project’s management and development components, with Vodafone’s technology, infrastructure and expertise as the backbone behind its ideas.

Vodafone’s Director for its Machine to Machine program stated, “Bringing together the best in connectivity with the best in treatment and education will create powerful and compelling outcomes for patients. AstraZeneca is a global leader in the mHealth field and we are delighted to work with them to develop these innovative services.”

Share

Featured Articles

The Taiwan Excellence Award Winners on new technologies

Cypress Technology, Dacian Technology Material, Chroma ATE, Taiwan Advanced Nanotech & iDRC Chyng Hong Electronics are the Taiwan Excellence Award Winners

World Hepatitis Summit 2022 to support healthcare workers

The World Hepatitis Summit 2022 calls to prevent viral hepatitis as cases soar in children and healthcare workers struggle with the stigma

5 minutes with Yoni Nevo, CEO of Sweetch

At behavioural science company Sweetch, CEO Yoni Nevo treats chronic illnesses with digital therapeutics solutions, using AI & emotional intelligence

Canada’s telehealth support for Ukrainian healthcare workers

Technology & AI

How Contura’s hydrogel technology can help patients knees

Technology & AI

MVP Health Care’s Kim Kilby on hybrid healthcare’s future

Hospitals